(Q42982620)

12 November 2017

title

Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial (English)

1 reference

12 November 2017

1 reference

5

1 reference

12 November 2017

C Cursaro

3

0 references

author name string

P Andreone

1

1 reference

12 November 2017

A Gramenzi

2

1 reference

12 November 2017

F Felline

4

1 reference

12 November 2017

A D'Errico

6

1 reference

12 November 2017

M Spinosa

7

1 reference

12 November 2017

S Lorenzini

8

1 reference

12 November 2017

M Biselli

9

1 reference

12 November 2017

M Bernardi

10

1 reference

12 November 2017

publication date

1 January 2004

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

11

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

69-73

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

Interaction between the hepatitis C virus and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

New therapeutic strategies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00470.X

10.1046/J.1365-2893.2003.00470.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference